[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.130.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 6, 1948

THE PAPANICOLAOU TEST FOR UTERINE CANCER

Author Affiliations

vice president, Clay-Adams Company, Inc., New York 10.

JAMA. 1948;136(10):711. doi:10.1001/jama.1948.02890270053022

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  In The Journal of the American Medical Association, January 31, page 331, the editorial on "The Papanicolaou Test for Uterine Cancer" concludes with the paragraph:"Recently a manufacturer of laboratory equipment has promoted the sale of the materials for the Papanicolaou test together with a hundred slides of various types of cells found in cervical smears. The firm cannot, however, sell the most important ingredient—a competent pathologist to study the specimen promptly after it is secured from the patient. The offer implies that special training is not necessary to secure and to examine the specimen. The indiscriminate use of this test will result in more harm than good."We wish to take exception to the statement, "the offer implies that special training is not necessary to secure and to examine the specimen." Our advertisement (adv. p. 54) in the Dec. 27, 1947 issue of The Journal very

First Page Preview View Large
First page PDF preview
First page PDF preview
×